drugset / Trial / NCT01350102

The Relationship of Hemoglobin A1c and Diabetic Wound Healing

NCT01350102

Phase 4 Terminated 2 enrolled Susan Hassenbein
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will be done to evaluate impact on time to wound closure.

Timeline

Start
2012-02
Primary completion
2014-03
Completion
2014-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator AmeriGel Unknown
Comparator Bacitracin Unknown